G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acids

被引:51
作者
Del Guerra, S. [1 ]
Bugliani, M. [1 ]
D'Aleo, V. [1 ]
Del Prato, S. [1 ]
Boggi, U. [1 ]
Mosca, F. [1 ]
Filipponi, F. [1 ]
Lupi, R. [1 ]
机构
[1] Univ Pisa, Dip Endocrinol & Metab, Sezione Metab, Osped Cisanello, I-56124 Pisa, Italy
关键词
Human pancreatic islets; Free-fatty acids; Type; 2; diabetes; G protein-coupled receptors; INSULIN-SECRETION; BETA-CELL; LIPOTOXICITY; GENE;
D O I
10.1016/j.numecd.2009.02.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: GPR40 is a membrane-bound receptor paired with medium and long-chain fatty acids (FFA) as endogenous ligands. Its acute activation potentiates insulin secretion from beta cells, whereas prolonged binding might contribute to the deleterious effects of chronic exposure to FFA. Little information is available on the expression of GPR40 and its regulation in human islets (HI). Material and methods: HI were prepared by enzymatic digestion and gradient separation from the pancreas of 20 non-diabetic (Ctrl) and 13 type 2 diabetic (T2DM) multiorgan donors, and functional and molecular studies were then performed. Results: By qualitative and quantitative PCR experiments, mRNA expression was shown in HI. Both in T2DM islets and in Ctrl islets pre-exposed for 24 h to 1.0 mmol/l FFA (palmitate: oleate, 2: 1), GPR40 mRNA expression was significantly reduced (p < 0.01) in the T2DM cells as compared to Ctrl cells. A significant positive correlation was found between glucose-stimulated insulin secretion and GPR40 expression. Conclusions: These results show the expression of GPR40 in human pancreatic islets which are regulated by FFA. The finding that T2DM islets have a lower GPR40 expression, and the correlation of these genes with insulin secretion, raises the possibility of an involvement of GPR40 in human diabetes beta-cell dysfunction. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:22 / 25
页数:4
相关论文
共 24 条
[1]   Novel aspects on signal-transduction in the pancreatic β-cell [J].
Berggren, PO ;
Leibiger, IB .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 :S7-S10
[2]  
BODEN G, 1999, P ASS AM PHYS, V241, P241
[3]   Protection of pancreatic beta-cells: Is it feasible? [J].
Bonora, Enzo .
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (01) :74-83
[4]   Dysfunctional fat cells, lipotoxicity and type 2 diabetes [J].
DeFronzo, RA .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 :9-21
[5]   New insights into fatty acid modulation of pancreatic β-cell function [J].
Haber, EP ;
Procópio, J ;
Carvalho, CRO ;
Carpinelli, AR ;
Newsholme, P ;
Curi, R .
INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 248, 2006, 248 :1-+
[6]   Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40 [J].
Itoh, Y ;
Kawamata, Y ;
Harada, M ;
Kobayashi, M ;
Fujii, R ;
Fukusumi, S ;
Ogi, K ;
Hosoya, M ;
Tanaka, Y ;
Uejima, H ;
Tanaka, H ;
Maruyama, M ;
Satoh, R ;
Okubo, S ;
Kizawa, H ;
Komatsu, H ;
Matsumura, F ;
Noguchi, Y ;
Shinobara, T ;
Hinuma, S ;
Fujisawa, Y ;
Fujino, M .
NATURE, 2003, 422 (6928) :173-176
[7]   Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1 [J].
Katsuma, S ;
Hatae, N ;
Yano, T ;
Ruike, Y ;
Kimura, M ;
Hirasawa, A ;
Tsujimoto, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (20) :19507-19515
[8]  
LAN H, 2008, DIABETES 0804
[9]   Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger [J].
Lupi, R. ;
Del Guerra, S. ;
Mancarella, R. ;
Novelli, M. ;
Valgimigli, L. ;
Pedulli, G. F. ;
Paolini, M. ;
Soleti, A. ;
Filipponi, F. ;
Mosca, F. ;
Boggi, U. ;
Del Prato, S. ;
Masiello, P. ;
Marchetti, P. .
DIABETES & METABOLISM, 2007, 33 (05) :340-345
[10]   Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets -: Evidence that β-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated [J].
Lupi, R ;
Dotta, F ;
Marselli, L ;
Del Guerra, S ;
Masini, M ;
Santangelo, C ;
Patané, G ;
Boggi, U ;
Piro, S ;
Anello, M ;
Bergamini, E ;
Mosca, F ;
Di Mario, U ;
Del Prato, S ;
Marchetti, P .
DIABETES, 2002, 51 (05) :1437-1442